XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.4
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Nov. 30, 2022
Nov. 30, 2021
Cash provided (used) by operating activities:    
Net income $ 107,093 $ 183,970
Adjustments to reconcile net income to net cash provided (used) by operating activities:    
Depreciation and amortization 33,330 26,082
Amortization of financing costs 792 738
Non-cash operating lease expense 7,558 6,910
Provision for credit losses 1,373 292
Non-cash share-based compensation 32,055 28,349
Gain on sale of Personal Care business (1,336) (513)
Loss (gain) on the sale or disposal of property and equipment 5 (2,274)
Deferred income taxes and tax credits 1,479 (8,721)
Changes in operating capital, net of effects of acquisitions of businesses:    
Receivables (45,714) (139,292)
Inventory 28,996 (103,821)
Prepaid expenses and other current assets 3,926 (6,765)
Other assets and liabilities, net (1,113) (6,110)
Accounts payable (78,128) (30,549)
Accrued expenses and other current liabilities (22,945) 29,198
Accrued income taxes (17,848) 17,452
Net cash provided (used) by operating activities 49,523 (5,054)
Cash (used) provided by investing activities:    
Capital and intangible asset expenditures (146,194) (41,529)
Net payments to acquire businesses, net of cash acquired (146,342) 0
Proceeds from sale of Personal Care business 1,804 44,700
Proceeds from the sale of property and equipment 63 5,305
Net cash (used) provided by investing activities (290,669) 8,476
Cash provided (used) by financing activities:    
Proceeds from revolving loans 633,500 461,400
Repayment of revolving loans (613,000) (356,400)
Proceeds from term loans 250,000 0
Repayments of Long-Term Debt (3,462) (1,900)
Payment of financing costs (586) 0
Proceeds from share issuances under share-based compensation plans 5,000 5,721
Payments for repurchases of common stock (18,350) (113,019)
Net cash provided (used) by financing activities 253,102 (4,198)
Net increase (decrease) in cash and cash equivalents 11,956 (776)
Cash and cash equivalents, beginning balance 33,381 45,120
Cash and cash equivalents, ending balance 45,337 44,344
Supplemental non-cash investing activity:    
Capital expenditures included in accounts payable $ 11,038 $ 8,140